Kallislahti, Finland

Esa Petteri Lahdenpaa

This inventor holds 1 USPTO granted patent. Top assignee: Orion-Yhtyma Oy. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Esa Petteri Lahdenpaa. Retrieved from https://idiyas.com/inventor/esa-petteri-lahdenpaa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Esa Petteri Lahdenpaa: Innovator in Controlled Release Technology

Introduction

Esa Petteri Lahdenpaa is a notable inventor based in Kallislahti, Finland. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of controlled release formulations. His innovative work has led to advancements that benefit patients requiring precise medication delivery.

Latest Patents

Esa Petteri Lahdenpaa holds a patent for a "Peroral composition for controlled release in the lower gastrointestinal tract." This invention is crucial for improving the efficacy of drug delivery systems, ensuring that medications are released at the right time and place within the body.

Career Highlights

Esa is currently employed at Orion-yhtyma Oy, a leading pharmaceutical company in Finland. His role involves research and development, where he focuses on creating advanced drug formulations that enhance patient outcomes. His expertise in controlled release technology has positioned him as a key player in the industry.

Collaborations

Esa has worked alongside talented colleagues, including Martti Lauri Marvola and Esko Veikko Marttila. Their collaborative efforts have contributed to the success of various projects within the company, fostering an environment of innovation and excellence.

Conclusion

Esa Petteri Lahdenpaa's contributions to controlled release technology exemplify the impact of innovative thinking in the pharmaceutical industry. His work continues to pave the way for advancements that improve patient care and medication efficacy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…